Kaul Inderjit reported NERV

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002095703-25-000005

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 14, 2025

Published

Nov 18, 2025

Ingested by INSIDER

Nov 5, 04:32 UTC

Last re-read

Nov 5, 04:32 UTC

Extracted facts

Filer

Kaul Inderjit

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Minerva Neurosciences, Inc. — Stock Option (right to buy)

Ticker

NERV

Shares

9,500

Price per share

$0

Execution date (reported)

Nov 14, 2025

Owned after transaction

9,500 shares

Days from execution to publication

4

What this establishes

Kaul Inderjit filed this Form 4 reporting a grant or award of NERV on Nov 14, 2025. It became public on Nov 18, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Kaul Inderjitcik:0002095703

Issuer

Minerva Neurosciences, Inc.cik:0001598646

Revision history · 0

No field has changed since this record was first ingested.